The groundbreaking rise of Sildenafil presented a massive chance for investors , but its exclusivity has ended, creating a challenging landscape. Alternative versions have entered the arena, eroding https://oisiyxcp782871.tkzblog.com/41336360/the-little-blue-pill-and-the-pharmaceutical-industry-a-uncertain-venture